Literature DB >> 25252036

GALNS mutations in Indian patients with mucopolysaccharidosis IVA.

Abdul Mueed Bidchol1, Ashwin Dalal, Hitesh Shah, Suryanarayana S, Sheela Nampoothiri, Madhulika Kabra, Neerja Gupta, Sumita Danda, Kalpana Gowrishankar, Shubha R Phadke, Seema Kapoor, Mahesh Kamate, I C Verma, Ratna Dua Puri, V H Sankar, A Radha Rama Devi, S J Patil, Prajnya Ranganath, S Jamal Md Nurul Jain, Meenal Agarwal, Ankur Singh, Pallavi Mishra, Parag M Tamhankar, Puthiya Mundyat Gopinath, H A Nagarajaram, Kapaettu Satyamoorthy, Katta Mohan Girisha.   

Abstract

Mucopolysaccharidosis IV A (Morquio syndrome A, MPS IVA) is a lysosomal storage disease caused by the deficiency of N-acetylgalactosamine-6-sulfatase (GALNS). The mutation spectrum in this condition is yet to be determined in Indians. We aimed to analyze the mutations in the GALNS gene in Asian Indians with MPS IVA. All the exons and the adjacent intronic regions of the gene were amplified and sequenced in sixty-eight unrelated Indian families. We identified 136 mutant alleles comprising of 40 different mutations. We report twenty-two novel mutations that comprise of seventeen missense (p.Asn32Thr, p.Leu36Arg, p.Pro52Leu, p.Pro77Ser, p.Cys79Arg, p.His142Pro, p.Tyr191Asp, p.Asn204Thr, p.Gly188Ser, p.Phe216Ser, p.Trp230Cys, p.Ala291Ser, p.Gly317Arg, p.His329Pro, p.Arg386Ser, p.Glu450Gly, p.Cys501Ser), three splice-site variants (c.120+1G>C, c.1003-3C>G, c.1139+1G>A), one nonsense mutation (p.Gln414*) and one frameshift mutation (p.Pro420Leufs*440). Eighteen mutations have been reported earlier. Among these p.Ser287Leu (8.82%), p.Phe216Ser (7.35%), p.Asn32Thr (6.61%) and p.Ala291Ser (5.88%) were the most frequent mutations in Indian patients but were rare in the mutational profiles reported in other populations. These results indicate that the Indian patients may have a distinct mutation spectrum compared to those of other populations. Mutant alleles in exon 1, 7 and 8 accounted for 44.8% of the mutations, and sequencing of these exons initially may be a cost-effective approach in Asian Indian patients. This is the largest study on molecular analysis of patients with MPS IVA reported in the literature, and the first report from India.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  GALNS gene; India; diagnosis; genetics; morquio syndrome A; mucopolysaccharidosis IVA; mutation

Mesh:

Substances:

Year:  2014        PMID: 25252036     DOI: 10.1002/ajmg.a.36735

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

1.  Oral immunotherapy tolerizes mice to enzyme replacement therapy for Morquio A syndrome.

Authors:  Angela C Sosa; Barbara Kariuki; Qi Gan; Alan P Knutsen; Clifford J Bellone; Miguel A Guzmán; Luis A Barrera; Shunji Tomatsu; Anil K Chauhan; Eric Armbrecht; Adriana M Montaño
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

2.  The GALNS p.P77R variant is a probable Gujarati-Indian founder mutation causing Mucopolysaccharidosis IVA syndrome.

Authors:  Harsh Sheth; Premal Naik; Maulin Shah; Riddhi Bhavsar; Aadhira Nair; Frenny Sheth; Jayesh Sheth
Journal:  BMC Genomics       Date:  2022-06-21       Impact factor: 4.547

Review 3.  Molecular basis of mucopolysaccharidosis IVA (Morquio A syndrome): A review and classification of GALNS gene variants and reporting of 68 novel variants.

Authors:  Alessandra Zanetti; Francesca D'Avanzo; Moeenaldeen AlSayed; Ana Carolina Brusius-Facchin; Yin-Hsiu Chien; Roberto Giugliani; Emanuela Izzo; David C Kasper; Hsiang-Yu Lin; Shuan-Pei Lin; Laura Pollard; Akashdeep Singh; Rodolfo Tonin; Tim Wood; Amelia Morrone; Rosella Tomanin
Journal:  Hum Mutat       Date:  2021-08-23       Impact factor: 4.700

4.  Medical genetics and genomic medicine in India: current status and opportunities ahead.

Authors:  Shagun Aggarwal; Shubha R Phadke
Journal:  Mol Genet Genomic Med       Date:  2015-05       Impact factor: 2.183

5.  Phenotype guided characterization and molecular analysis of Indian patients with long QT syndromes.

Authors:  Bijal Vyas; Ratna D Puri; Narayanan Namboodiri; Renu Saxena; Mohan Nair; Prahlad Balakrishnan; M P Jayakrishnan; Ameya Udyavar; Ravi Kishore; Ishwar C Verma
Journal:  Indian Pacing Electrophysiol J       Date:  2016-03-30

Review 6.  A review of skeletal dysplasia research in India.

Authors:  A Uttarilli; H Shah; A Shukla; K M Girisha
Journal:  J Postgrad Med       Date:  2018 Apr-Jun       Impact factor: 1.476

7.  The promise of discovering population-specific disease-associated genes in South Asia.

Authors:  Nathan Nakatsuka; Priya Moorjani; Niraj Rai; Biswanath Sarkar; Arti Tandon; Nick Patterson; Gandham SriLakshmi Bhavani; Katta Mohan Girisha; Mohammed S Mustak; Sudha Srinivasan; Amit Kaushik; Saadi Abdul Vahab; Sujatha M Jagadeesh; Kapaettu Satyamoorthy; Lalji Singh; David Reich; Kumarasamy Thangaraj
Journal:  Nat Genet       Date:  2017-07-17       Impact factor: 38.330

8.  Clinical, biochemical and genetic profiles of patients with mucopolysaccharidosis type IVA (Morquio A syndrome) in Malaysia: the first national natural history cohort study.

Authors:  Huey Yin Leong; Nor Azimah Abdul Azize; Hui Bein Chew; Wee Teik Keng; Meow Keong Thong; Mohd Khairul Nizam Mohd Khalid; Liang Choo Hung; Norzila Mohamed Zainudin; Azura Ramlee; Muzhirah Aisha Md Haniffa; Yusnita Yakob; Lock Hock Ngu
Journal:  Orphanet J Rare Dis       Date:  2019-06-14       Impact factor: 4.123

Review 9.  Epidemiology of Mucopolysaccharidoses Update.

Authors:  Betul Çelik; Saori C Tomatsu; Shunji Tomatsu; Shaukat A Khan
Journal:  Diagnostics (Basel)       Date:  2021-02-10

10.  Mutations in ARSB in MPS VI patients in India.

Authors:  Juby Mathew; Sujatha M Jagadeesh; Meenakshi Bhat; S Udhaya Kumar; Saravanamuthu Thiyagarajan; Sudha Srinivasan
Journal:  Mol Genet Metab Rep       Date:  2015-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.